PER 0.00% 7.8¢ percheron therapeutics limited

atl1103 anti cancer medications

  1. 2,843 Posts.
    Thought i would change the thread to more reflect on the Antisense business model ATL1103 for cancer diabetes and acromegaly.(all in huge demand gobally).

    http://somavert.com/

    Pfizer own this drug and you can research for yourselves the enormity of Somavert.

    If ATL1103 can deliver the clinical success as shown in Primates and after lots of research i believe we do have a 95% success rate in my viw, imagine the huge market demand for Antisense ATL1103.
    Globally it will be huge and ATL1103 should have a very good toxiclogy.
    In my view we are about to hit the big time.ISIS firmly on boardas a partner.Awaiting Clinical trial results eagerly.
    Robbbbsssttarrrrr

    http://imagesignal.comsec.com.au/asxdata/20110816/pdf/01207431.pdf
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $70.32M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $5.891K 75.05K

Buyers (Bids)

No. Vol. Price($)
1 6454 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 19621 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.